• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向晚期霍奇金淋巴瘤的治愈性治疗

Towards curative treatment of advanced Hodgkin's disease.

作者信息

Falkson H C, Falkson G

出版信息

S Afr Med J. 1975 Sep 6;49(38):1545-9.

PMID:1179225
Abstract

Advanced Hodgkin's disease was considered incurable until 1966. The development of combined chemotherapy has led to intensIVe treatment and to cures. Results obtained in 104 patients treated according to acute leukaemia group B protocols are discussed. Staging according to the Rye classification was used, as these patients were treated from 1966 to 1971. Methodology and dosage schemes are discussed. Reponse rates reached 88%, with extended survival. The modifications of therapeutic schedules which led to long-term, unmaintained remissions, are explained. The 5-year survival rate of patients with Hodgkin's disease in stages III and iv who responded, was 82,7%. The effect of histological subclassification on the prognosis is considered. The importance of accurate documentation is stressed, and also the use of laparotomy to prove the staging of the disease so as not to deny the patient the benefit of potential cure with chemotherapy.

摘要

直到1966年,晚期霍奇金病还被认为是无法治愈的。联合化疗的发展带来了强化治疗并实现了治愈。本文讨论了按照急性白血病B组方案治疗的104例患者所取得的结果。由于这些患者是在1966年至1971年期间接受治疗的,因此采用了Rye分类法进行分期。文中讨论了方法和剂量方案。缓解率达到88%,生存期延长。解释了导致长期、无需维持的缓解的治疗方案修改情况。有反应的III期和IV期霍奇金病患者的5年生存率为82.7%。文中考虑了组织学亚分类对预后的影响。强调了准确记录的重要性,以及使用剖腹术来证实疾病分期的重要性,以免使患者无法从化疗潜在治愈中获益。

相似文献

1
Towards curative treatment of advanced Hodgkin's disease.迈向晚期霍奇金淋巴瘤的治愈性治疗
S Afr Med J. 1975 Sep 6;49(38):1545-9.
2
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Arch Intern Med. 1973 Mar;131(3):396-401.
3
Letter: Chemotherapy of Hodgkin's disease.
N Engl J Med. 1974 Dec 12;291(24):1309. doi: 10.1056/NEJM197412122912416.
4
Pediatric Hodgkin's disease.小儿霍奇金病
J Ky Med Assoc. 2004 Mar;102(3):104-6.
5
[Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].[霍奇金淋巴瘤的治疗。圣路易医院的经验]
Rev Prat. 1974 Oct 11;24(45):3971-8.
6
Combination chemotherapy and survival in advanced Hodgkin's disease.
Arch Intern Med. 1973 Mar;131(3):388-90.
7
Combination chemotherapy in advanced and recurrent Hodgkin's disease.晚期及复发性霍奇金病的联合化疗
Natl Cancer Inst Monogr. 1973 May;36:395-402.
8
The use of different drugs and combinations in the treatment of Hodgkin's disease.
Ser Haematol. 1973;6(2):196-201.
9
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?在晚期霍奇金病的治疗中,MOPP方案能否被替代?
Semin Oncol. 1990 Feb;17(1 Suppl 2):2-6.
10
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.霍奇金病的联合药物治疗:缓解诱导、缓解持续时间及生存率;一项评估
Natl Cancer Inst Monogr. 1973 May;36:373-9.